B. Combe

1.5k total citations
22 papers, 959 citations indexed

About

B. Combe is a scholar working on Rheumatology, Hematology and Immunology. According to data from OpenAlex, B. Combe has authored 22 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 6 papers in Hematology and 5 papers in Immunology. Recurrent topics in B. Combe's work include Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). B. Combe is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (16 papers), Systemic Lupus Erythematosus Research (5 papers) and Autoimmune and Inflammatory Disorders Research (5 papers). B. Combe collaborates with scholars based in France, Netherlands and United Kingdom. B. Combe's co-authors include Rachel Audo, Michael Hahne, Jacques Morel, Alain Cantagrel, C. Daïen, Thibault Mura, J Sany, H. Zeidler, Marjatta Leirisalo‐Repo and Peggy L. Olive and has published in prestigious journals such as Journal of Biological Chemistry, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

B. Combe

21 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Combe France 13 638 301 247 159 151 22 959
Eva Pérez‐Pampín Spain 20 665 1.0× 331 1.1× 173 0.7× 182 1.1× 162 1.1× 62 1.1k
Kouichi Amano Japan 15 575 0.9× 216 0.7× 165 0.7× 89 0.6× 143 0.9× 35 758
Charles Ludivico United States 9 741 1.2× 268 0.9× 352 1.4× 77 0.5× 228 1.5× 13 1.0k
Šárka Forejtová Czechia 15 1.0k 1.6× 401 1.3× 403 1.6× 212 1.3× 195 1.3× 32 1.4k
Norifumi Sawamukai Japan 14 359 0.6× 267 0.9× 134 0.5× 103 0.6× 97 0.6× 25 672
Yvonne Sherrer United States 7 921 1.4× 441 1.5× 391 1.6× 72 0.5× 218 1.4× 11 1.3k
Z Domljan Croatia 6 667 1.0× 302 1.0× 304 1.2× 260 1.6× 106 0.7× 18 1.1k
Edit Drescher United States 13 922 1.4× 486 1.6× 463 1.9× 116 0.7× 211 1.4× 35 1.3k
M. C. Genovese United States 10 634 1.0× 228 0.8× 320 1.3× 53 0.3× 162 1.1× 38 842
J Jäger Australia 3 1.2k 1.9× 294 1.0× 577 2.3× 73 0.5× 255 1.7× 5 1.4k

Countries citing papers authored by B. Combe

Since Specialization
Citations

This map shows the geographic impact of B. Combe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Combe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Combe more than expected).

Fields of papers citing papers by B. Combe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Combe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Combe. The network helps show where B. Combe may publish in the future.

Co-authorship network of co-authors of B. Combe

This figure shows the co-authorship network connecting the top 25 collaborators of B. Combe. A scholar is included among the top collaborators of B. Combe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Combe. B. Combe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lukas, Cédric, C. Daïen, C. Gaujoux-Viala, et al.. (2025). Polypharmacy in Early Rheumatoid Arthritis: Impact on Treatment Response and Adverse Event Risk in a multicenter French prospective cohort study. ACR Open Rheumatology. 7(8). e70066–e70066. 1 indexed citations
2.
Audo, Rachel, Dany Séverac, Christelle Le Dantec, et al.. (2015). Identification of genes regulating TRAIL-induced apoptosis in rheumatoid arthritis fibroblasts-like synoviocytes. Genes and Immunity. 16(7). 462–469. 10 indexed citations
3.
Cacoub, P., B. Combe, Jean Sibilia, et al.. (2015). Late-onset neutropenia after treatment with rituximab for rheumatoid arthritis and other autoimmune diseases: data from the AutoImmunity and Rituximab registry. RMD Open. 1(1). e000034–e000034. 56 indexed citations
4.
Emery, Paul, Vivian P. Bykerk, B. Combe, et al.. (2014). OP0026 Induction of Clinical Remission Followed by Drug-Free Withdrawal with Abatacept Combination and Monotherapy in Early RA: Results from the AVERT Study over 18 Months. Annals of the Rheumatic Diseases. 73. 69–69. 7 indexed citations
5.
Daïen, C., Thibault Mura, Rachel Audo, et al.. (2014). Regulatory B10 Cells Are Decreased in Patients With Rheumatoid Arthritis and Are Inversely Correlated With Disease Activity. Arthritis & Rheumatology. 66(8). 2037–2046. 122 indexed citations
6.
7.
Ruyssen‐Witrand, Adeline, Stéphanie Rouanet, B. Combe, et al.. (2012). Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients. Lara D. Veeken. 52(4). 636–641. 38 indexed citations
8.
Combe, B., et al.. (2011). Tocilizumab - a new step in rheumatoid arthritis treatment.. PubMed. 35(3). 302–12. 9 indexed citations
9.
Audo, Rachel, et al.. (2011). Mechanisms and clinical relevance of TRAIL‐triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis. Arthritis & Rheumatism. 63(4). 904–913. 19 indexed citations
10.
Audo, Rachel, Dominique Baeten, Angélique Bruyer, et al.. (2011). Mechanisms and clinical relevance of TRAIL-triggered responses in synovial fibroblasts of rheumatoid arthritis patients. Annals of the Rheumatic Diseases. 70. A33–A34. 3 indexed citations
11.
Funovits, Julia, D. Aletaha, Vivian P. Bykerk, et al.. (2010). The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological Report Phase I. Annals of the Rheumatic Diseases. 69(9). 1589–1595. 135 indexed citations
12.
Fautrel, Bruno, Mathilde Benhamou, Violaine Foltz, et al.. (2009). Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort. Lara D. Veeken. 49(1). 147–155. 24 indexed citations
13.
Emery, Paul, Ronald van Vollenhoven, M. Østergaard, et al.. (2009). Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe. Annals of the Rheumatic Diseases. 68(4). 456–459. 38 indexed citations
14.
Puéchal, Xavier, Jean Sibilia, Xavier Mariette, et al.. (2009). Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial. Lara D. Veeken. 48(11). 1429–1434. 80 indexed citations
15.
Combe, B., Ugo Fiocco, M. Gaubitz, et al.. (2007). Double-blind comparison of etanercept and sulfasalazine, alone and combined in active RA patients. Document Server@UHasselt (UHasselt). 2 indexed citations
16.
Morel, Jacques, Rachel Audo, Michael Hahne, & B. Combe. (2005). Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) Induces Rheumatoid Arthritis Synovial Fibroblast Proliferation through Mitogen-activated Protein Kinases and Phosphatidylinositol 3-Kinase/Akt. Journal of Biological Chemistry. 280(16). 15709–15718. 141 indexed citations
17.
Eliaou, J-F, et al.. (2001). HLA-DRB1 genes and patients with late onset rheumatoid arthritis. Annals of the Rheumatic Diseases. 60(5). 531–533. 25 indexed citations
18.
Combe, B., Alain Cantagrel, Peggy L. Olive, et al.. (1999). Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Annals of the Rheumatic Diseases. 58(4). 220–225. 186 indexed citations
19.
Anaya, Juan‐Manuel, et al.. (1992). [Therapeutic maintenance dose with methotrexate in rheumatoid polyarthritis. Prospective study of 191 cases].. PubMed. 59(3). 181–7. 5 indexed citations
20.
Sany, J, et al.. (1990). [Long-term tolerability of tiopronin (Acadione) in the treatment of rheumatoid arthritis. Apropos of 140 personal cases].. PubMed. 57(2). 105–11. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Pérez‐Pampín Breakdown of academic impact, for papers by Kouichi Amano Breakdown of academic impact, for papers by Charles Ludivico Breakdown of academic impact, for papers by Šárka Forejtová Breakdown of academic impact, for papers by Norifumi Sawamukai Breakdown of academic impact, for papers by Yvonne Sherrer Breakdown of academic impact, for papers by Z Domljan Breakdown of academic impact, for papers by Edit Drescher Breakdown of academic impact, for papers by M. C. Genovese Breakdown of academic impact, for papers by J Jäger
Rankless by CCL
2026